Form 4 for HCA HCA Healthcare
Accepted 2023-01-25 00:00:00 ET · period of report 2023-01-23 · accession 0001209191-23-004910 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-25 | 2023-01-23 | HCA | Paslick P. Martin | SVP, CIO | F - Tax | $263.81 | -2,966 | 22.1K | -12% | -$782.5K |
| D | 2023-01-25 | 2023-01-23 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $81.96 | +6,000 | 25.1K | +31% | +$491.8K |
| D | 2023-01-25 | 2023-01-23 | HCA | Paslick P. Martin | SVP, CIO | M - OptEx | $0.00 | -6,000 | 12.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-23 | F | D | 2,966 | $263.81 | 22,146 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-23 | M | A | 6,000 | $81.96 | 25,112 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2023-01-23 | M | D | 6,000 | $0.00 | 12,340 | D | $81.96 · — to 2027-02-01 | 6,000 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |